Naviscan PET scanners performing positron emission mammography (PEM) have been installed in two European centers: Radiologie und Nuklearmedizin in Ludwigshafen, Germany, and Medica in Istanbul, Turkey.
University of Texas (UT) Southwestern Medical Center in Dallas has installed a PET scanner, the breast application for which is positron emission mammography (PEM), which will be used both for clinical patients as well as for research focused on lowering radiation dose and novel radiotracers.
The National Institute of Cancer, a Mexican oncologic center, is the first in the country to offer positron emission mammography (PEM), which is a breast application of Naviscan's PET scanner that shows the location as well as the metabolic phase of a lesion.
18F-FDG uptake values measured by positron emission mammography (PEM) correlated with prognostic indicators that predict breast cancer survival and inform clinical management, including receptor status, tumor histology and tumor grade, according to a study published in the August issue of
American Journal of Roentgenology.
Written by James Brice
A new day is dawning for breast cancer diagnosis, treatment and monitoring with the help of molecular imaging.
RSS 
